Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics & Global Health World Congress

Wilbur Lam's Biography



Wilbur Lam, Assistant Professor, Georgia Institute Of Technology

Wilbur A. Lam, MD, PhD is an Assistant Professor of Biomedical Engineering and Pediatrics at the Georgia Institute of Technology and Emory University and is a physician-scientist-engineer with backgrounds in pediatric hematology/oncology and bioengineering. Dr. Lam obtained his BA in biosciences from Rice University, MD from Baylor College of Medicine, and his PhD in bioengineering from UC Berkeley and UCSF, where he also completed his clinical training in pediatrics and pediatric hematology/oncology. Dr. Lam’s interdisciplinary laboratory serves as a unique “one-stop shop” in which they develop microsystems (microfabricated devices, microfluidics, etc.) to study hematologic processes in both health and disease and then translates those technologies to the patient bedside. Dr. Lam has also co-founded and serves as chief medical officer for two medical device startups and is the co-PI of the Atlantic Pediatric Device Consortium, an FDA-funded, Atlanta-based academic consortium charged to invent, develop, and commercialize medical devices to diagnose and treat pediatric illnesses. His laboratory’s research is funded by the NIH, NSF, FDA, the American Heart Association, and the Department of Defense.

Wilbur Lam Image

Breakfast Briefing: A Disposable, Visual, Color-Based, Patient-Operated Anemia Diagnostic

Wednesday, 30 September 2015 at 08:00

Add to Calendar ▼2015-09-30 08:00:002015-09-30 09:00:00Europe/LondonBreakfast Briefing: A Disposable, Visual, Color-Based, Patient-Operated Anemia DiagnosticPoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Our laboratory has recently developed a rapid, stand-alone, and disposable anemia test that, via a single drop of capillary blood, outputs color-based results that correlate with hemoglobin (Hgb) levels and can be assessed with the naked eye or an optional smartphone app. We have recently published a clinical assessment demonstrating that results from our system correlated with gold standard hematology analyzer Hgb levels (r = 0.864 and r = 0.856 for visual interpretation and smartphone app, respectively), and both test methods yielded comparable sensitivity and specificity for detecting any anemia (n = 178) (<11 g/dl) (sensitivity: 90.2% and 91.1%, specificity: 83.7% and 79.2%, respectively) and severe anemia (n = 10) (<7 g/dl) (sensitivity: 90.0% and 100%, specificity: 94.6% and 93.9%, respectively). These results demonstrate the feasibility of this color-based diagnostic test for anemia self-screening in the general population, self-monitoring for chronic anemia patients, and most importantly, as an inexpensive anemia diagnostic in low resource settings. Work on all of these fronts is currently ongoing.


Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health World CongressPoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com